These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2177585)

  • 1. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):294-7. PubMed ID: 2544533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injection.
    Marquardt ED
    Am J Hosp Pharm; 1990 Aug; 47(8):1802-3. PubMed ID: 2389789
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
    Schaaf LJ; Tremel LC; Wulf BG; Vernon KK
    J Clin Pharm Ther; 1990 Oct; 15(5):371-6. PubMed ID: 1963175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
    Savitsky ME
    Am J Hosp Pharm; 1990 Apr; 47(4):820-1. PubMed ID: 1969713
    [No Abstract]   [Full Text] [Related]  

  • 16. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):250-4. PubMed ID: 2737791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual compatibility of narcotic analgesics with selected intravenous admixtures.
    Smythe MA; Patel MA; Gasloli RA
    Am J Hosp Pharm; 1990 Apr; 47(4):819-20. PubMed ID: 1969712
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of perphenazine with various antimicrobials during simulated Y-site injection.
    Gasca M; Fanikos J; Souney PF
    Am J Hosp Pharm; 1987 Mar; 44(3):574-5. PubMed ID: 3565416
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.